PD-L1 in cells within the tumor microenvironment and lymph nodes may matter more than PD-L1 in tumors, researchers report in a new study.

Researchers have identified and characterized a new type of RNA protein called THOR that plays a role in cancer development — and could serve as a target for drug development.

Cancer can damage undifferentiated naive T cells, which keeps the fighter cells from doing their job.

Suppressive Treg cells become even more suppressive when they die, a new study finds.

Fruit flies are far more than a kitchen nuisance. Learn how the pests and other tiny critters are helping researchers find major clues to human disease.

When will we cure breast cancer? See how breast cancer treatment has evolved since 1960 and find out what the future of breast cancer treatment and research holds.

As her young daughter battles a brain tumor, a mother advocates for more research — and funding — to combat childhood cancers of all kinds.

Donated tumor tissue from a 5-year-old brain cancer patient uncovers the key and early role of a less-understood genetic mutation in the cancer’s fatal course.

Learn about CAR T-cell therapy, a state-of-the-art FDA approved leukemia gene therapy, which the University of Michigan C.S. Mott Children's Hospital offers.

Clinical trials for new cancer treatments are most effective when a diverse group of patients participates. Michigan Medicine wants more patients to get involved.

A new study finds Fusobacterium nucleatum promotes resistance to chemotherapy in colon cancer patients. Read more about gut bacterium, f. nucleatum and colorectal cancer.

Michigan Medicine oncologists highlight some of the top findings that came from the field’s largest professional meeting.

For the first time, researchers have found an important factor that mitigates immune suppression in cancer.

Tissue and blood samples taken from patients can hold the keys to biomedical discovery. But the research community must consider patient privacy, a new perspective says.

Participation in clinical trials is one way a mother fights back against cancer. She also volunteers with cancer patients and is working to boost research funds to study her own disease.